Clinical Utility of NGS in Lymphoid Malignancies including Minimal Residual Disease (MRD) testing ← ALL VIDEOS Clinical Utility of NGS in Lymphoid Malignancies including Minimal Residual Disease (MRD) testing November 16th, 2020 FEATURED PRESENTERS Yury Monczak, Ph.D / Ryan J. Schmidt, MD, PhD 2025-06-11T10:44:14-07:00
